By Sriparna Roy (Reuters) -The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo’s precision drug to treat a type of breast cancer, the health regulator said on Friday. The treatment, jointly developed with the Japanese company, was branded as Datroway and approved for patients with an advanced form of breast cancer who had received prior treatment. The list